 |
Zangani Investor Community
|
|
At Zangani, our vision is two-fold. First we give the investment community a voice in evaluating the companies we represent. Second, we give our clients a savvy audience with a keen eye for investment opportunities. We believe the speed at which our clients’ information is disseminated, directly reflects the speed at which the investment community can access and act on that information.
Short URL for this Podcast |
 | |
|
|
Details
|
More Shows
|
Business
Business
Business
|
| Date Added |
04-Apr-2006 |
Hits: |
290 |
Rating: |
0.00 |
Votes: |
0 |
|
|
 |
Zangani - Webcasts Episodes - | Rodman & Renshaw Conference Call: A Discussion on Late Stage Obesity Drugs | Elemer Piros, Ph.D., Senior Biotechnology Analyst at Rodman & Renshaw, hosted their latest executive conference call.
A Discussion on Late Stage Obesity Drugs
Featured:
Jack Lief, President and CEO, Arena Pharmaceuticals
Timothy E. Morris, Vice President, Finance & CFO, Vivus
Michael Narachi, President and CEO, Orexigen Therapeutics
read more | Get at Short URL | Download Rodman & Renshaw Conference Call: A Discussion on Late Stage Obesity Drugs | Play in Popup.
| | | |
| Zangani Interviews John B. Nano, President of Competitive Technologies, Regarding the Recent FDA Approval | Zangani Investor Community(TM) interviews John B. Nano, Chairman, President and Chief Executive Officer of Competitive Technologies, Inc.
Mr. Nano discusses CTT's recently approved FDA application regarding the non-invasive pain management technology developed in Italy, and what this means for the future of CTT and it's shareholders.
Mr. Nano is a graduate of MIT's Sloan School Executive Program, holds an MBA in Finance from Northeastern University, and a BS in Chemical Engineering from Worcester Polytechnic Institute.
read more | Get at Short URL | Download Zangani Interviews John B. Nano, President of Competitive Technologies, Regarding the Recent FDA Approval | Play in Popup.
| | | |
| Interview with John B. Nano, Chairman, President and CEO of Competitive Technologies, Inc. | Zangani Investor Community(TM) interviews John B. Nano, Chairman, President and Chief Executive Officer of Competitive Technologies, Inc.
Mr. Nano discusses CTT's pending FDA application regarding the non-invasive pain management technology developed in Italy, and how the company is working to commercialize the device within the United States.
read more | Get at Short URL | Download Interview with John B. Nano, Chairman, President and CEO of Competitive Technologies, Inc. | Play in Popup.
| | | |
| Rodman & Renshaw: American Heart Association 2008 Wrap Up Call | Rodman & Renshaw and MedKnowledge host the latest in a series of medical expert conference calls.
Featuring:
* Christopher James, MD, Senior Biotechnology Analyst
* Barry H. Greenberg, MD, Professor of Medicine, Director Advanced Heart Failure Program
( President Heart Failure Society of America, University of California, San Diego UCSD Medical Center )
Dr. Barry Greenberg, Director, Advanced Heart Failure Treatment Program, has distinguished himself as a leading cardiologist. He is a founding member and current President of the Heart Failure Society of America (HFSA).
read more | Get at Short URL | Download Rodman & Renshaw: American Heart Association 2008 Wrap Up Call | Play in Popup.
| | | |
| Rodman & Renshaw / Life Sciences: ASBMR Wrap Up Conference Call | View From The Boneyard: An Analysis of the Pivotal Trials Presented at ASBMR, Including Denosumab, Lasofoxifene, and Odanacatib
Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls. Michael G. King, Jr., Senior Biotechnology Analyst, hosts the call featuring:
E. Michael Lewiecki, MD - Clinical Assistant Professor, Medicine at University of New Mexico School of Medicine. Director, New Mexico Clinical Research & Osteoporosis Center
Michael McClung, MD - Founding Director, Oregon Osteoporosis Center
read more | Get at Short URL | Download Rodman & Renshaw / Life Sciences: ASBMR Wrap Up Conference Call | Play in Popup.
| | | |
| Rodman & Renshaw Second Quarter 2008 Earnings Conference Call | Rodman & Renshaw hosts a conference call, with Michael Lacovara and David Horin, Rodman & Renshaw Capital Group?s Chief Executive Officer and Chief Financial Officer, respectively, discussing the Company's quarterly results.
About Rodman & Renshaw Capital Group, Inc.
Rodman & Renshaw Capital Group, Inc. is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC, Rodman Principal Investments, LLC and Miller Mathis & Co., LLC.
read more | Get at Short URL | Download Rodman & Renshaw Second Quarter 2008 Earnings Conference Call | Play in Popup.
| | | |
|
|
|
